Found: 2
Select item for more details and to access through your institution.
The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy.
- Published in:
- Biomedicines, 2024, v. 12, n. 5, p. 1101, doi. 10.3390/biomedicines12051101
- By:
- Publication type:
- Article
A Phase II Study of Neoadjuvant Chemoradiotherapy with Docetaxel, Cisplatin and 5-FU Followed by Surgical Resection in the Treatment of Locally Advanced Esophagogastric Junction Cancer and Locally Advanced Esophageal Cancer.
- Published in:
- Clinics & Practice, 2024, v. 14, n. 2, p. 642, doi. 10.3390/clinpract14020051
- By:
- Publication type:
- Article